Decreased expression of miR-430 promotes the development of bladder cancer via the upregulation of CXCR7

被引:37
|
作者
Liu, Lei [1 ]
Zhao, Xiaokun [1 ]
Zhu, Xuan [1 ]
Zhong, Zhaohui [1 ]
Xu, Ran [1 ]
Wang, Zijian [1 ]
Cao, Jian [1 ]
Hou, Yi [1 ]
机构
[1] Cent S Univ, Xiangya Hosp 2, Dept Urol, Changsha 410011, Hunan, Peoples R China
关键词
bladder cancer; microRNA-430; CXCR7; MATRIX METALLOPROTEINASES; MICRORNAS; CELLS;
D O I
10.3892/mmr.2013.1477
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) have been demonstrated to be involved in the development of numerous types of malignant tumor. However, the role of miRNA-430 (miR-430) in bladder cancer remains unclear. In the present study, we observed that the expression of miR-430 was significantly downregulated in bladder cancer. Furthermore, the overexpression of miR-430 in human bladder cancer 5637 cells significantly inhibited cell proliferation, migration and colony formation efficiency. These findings were contrary to those obtained following the overexpression of CXCR7, which was found to be a direct target of miR-430 in this study. Further analysis showed that cell proliferation- and migration-related genes, including ERK, matrix metalloproteinase-2 (MMP-2) and MMP-9, were significantly downregulated in miR-430 overexpressed 5637 cells, while they were markedly upregulated in CXCR7 overexpressed 5637 cells. In conclusion, our study reveals important roles of miR-430 and CXCR7 in bladder cancer, and suggests that the downregulation of miR-430 enhances the development of bladder cancer, partly via the upregulation of CXCR7.
引用
收藏
页码:140 / 146
页数:7
相关论文
共 50 条
  • [21] Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer
    Nazari, Alireza
    Khorramdelazad, Hossein
    Hassanshahi, Gholamhossein
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (06) : 991 - 1000
  • [22] Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer
    Alireza Nazari
    Hossein Khorramdelazad
    Gholamhossein Hassanshahi
    International Journal of Clinical Oncology, 2017, 22 : 991 - 1000
  • [23] The CXCL12/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer
    Leilei Xu
    Changhua Li
    Fu Hua
    Xiaoping Liu
    Medical Oncology, 2021, 38
  • [24] Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth
    Gritsina, Galina
    Fong, Ka-wing
    Lu, Xiaodong
    Lin, Zhuoyuan
    Xie, Wanqing
    Agarwal, Shivani
    Lin, Dong
    Schiltz, Gary E.
    Beltran, Himisha
    Corey, Eva
    Morrissey, Colm
    Wang, Yuzhuo
    Zhao, Jonathan C.
    Hussain, Maha
    Yu, Jindan
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (15):
  • [25] The CXCL12/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer
    Xu, Leilei
    Li, Changhua
    Hua, Fu
    Liu, Xiaoping
    MEDICAL ONCOLOGY, 2021, 38 (05)
  • [26] Lipopolysaccharide Promotes Choroidal Neovascularization by Up-Regulation of CXCR4 and CXCR7 Expression in Choroid Endothelial Cell
    Feng, Yi-fan
    Guo, Hua
    Yuan, Fei
    Shen, Min-qian
    PLOS ONE, 2015, 10 (08):
  • [27] Expression of SDF-1 and CXCR4 transcript variants and CXCR7 in epithelial ovarian cancer
    Jaszczynska-Nowinka, Karolina
    Rucinski, Marcin
    Ziolkowska, Agnieszka
    Markowska, Anna
    Malendowicz, Ludwik K.
    ONCOLOGY LETTERS, 2014, 7 (05) : 1618 - 1624
  • [28] c-Met activation promotes epithelial-to-mesenchymal transition (EMT) in renal cancer cells through the upregulation of the chemokine receptor CXCR7
    Chakraborty, Samik
    Balan, Murugabaskar
    Pal, Soumitro
    CANCER RESEARCH, 2019, 79 (13)
  • [29] FoxH1 represses miR-430 during early embryonic development of zebrafish via non-canonical regulation
    Patrick Fischer
    Hao Chen
    Frederic Pacho
    Dietmar Rieder
    Robin A. Kimmel
    Dirk Meyer
    BMC Biology, 17
  • [30] Correction to: Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer
    Alireza Nazari
    Hossein Khorramdelazad
    Gholamhossein Hassanshahi
    International Journal of Clinical Oncology, 2018, 23 : 799 - 799